Form: S-3

Registration statement under Securities Act of 1933

March 13, 2026


Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
 
Opus Genetics, Inc.
(Exact Name of Registrant as Specified in its Charter)
 
Table 1: Newly Registered and Carry Forward Securities
             
  Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward
File Number
Carry Forward Initial effective date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward
Newly Registered Securities
Fees to Be Paid
Equity Common stock, $0.0001 par value per share Rule 457(c) 7,374,632 (2) $4.89 (3) $36,061,950.48(3) 0.0001381 $4,980.16 (3)        
Fees Previously Paid
N/A          
Carry Forward Securities
Carry Forward Securities
N/A —   
  Total Offering Amounts   $36,061,950.48   $4,980.16        
  Total Fees Previously Paid              
  Total Fee Offsets              
  Net Fee Due       $4,980.16        
  
(1)
In the event of a stock split, stock dividend or other similar transaction involving shares of the common stock, par value $0.0001 per share (“common stock”), of Opus Genetics, Inc. (the “Registrant”), in order to prevent dilution, the number of shares of common stock registered hereby shall be automatically increased to cover the additional shares of common stock in accordance with Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”).
  
(2)
Consists of the resale of 7,374,632 shares of common stock issuable upon the conversion of the Registrant’s Series B Non-Voting Convertible Preferred Stock, par value $0.0001 per share.
  
(3)
Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act. The price per share and aggregate offering price are based on the average of the high and low prices of common stock on March 9, 2026, as reported on the Nasdaq Capital Market.
 

N/A 0001228627 EX-FILING FEES N/A 0001228627 2026-03-13 2026-03-13 0001228627 1 2026-03-13 2026-03-13 xbrli:shares iso4217:USD xbrli:shares iso4217:USD xbrli:pure